These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1704168)

  • 21. Propafenone versus disopyramide: a double-blind randomized crossover trial in patients presenting chronic ventricular arrhythmias.
    Libersa C; Caron J; Pladys A; Beuscart R; Kacet S; Wajman A; Connell C; Dupuis B; Lekieffre J
    Clin Cardiol; 1987 Jul; 10(7):405-10. PubMed ID: 2440632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of the efficacy of propafenone and hydroquinidine in stabilized extrasystolic ventricular arrhythmia by means of dynamic electrocardiographic Holter monitoring].
    Rizzon P; De Toma L; Mangini SG; Lagioia R; Scrutinio D; Accettura D; De Nicolò M
    G Ital Cardiol; 1984 May; 14(5):345-51. PubMed ID: 6205924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group.
    Zoble RG; Kirsten EB; Brewington J
    Clin Pharmacol Ther; 1989 May; 45(5):535-41. PubMed ID: 2721109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole].
    Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Huguet R; Wajman A
    Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1495-505. PubMed ID: 2432845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of chronic ventricular extrasystole by propafenone (600 mg/d) in 2 or 3 daily doses].
    Lardoux H; Valère PE; Djiane P; Maarek-Charbit M
    Ann Cardiol Angeiol (Paris); 1993 May; 42(5):281-8. PubMed ID: 7690219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Propafenone: evaluation of antiarrhythmic efficacy in hyperkinetic ventricular arrhythmia using acute oral test].
    Boriani G; Capucci A; Balducelli M; Frabetti L; Marchesini B; Tomasi L; Ambrosioni E; Magnani B
    Cardiologia; 1988 Nov; 33(11):1061-7. PubMed ID: 2475253
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effectiveness of barucainide in supraventriculr and ventricular arrhythmias].
    Brugger P
    Z Kardiol; 1989 Aug; 78(8):510-8. PubMed ID: 2477959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial uptake and pharmacodynamics of quinidine and propafenone in isolated rabbit hearts: metabolic versus respiratory acidosis.
    Gillis AM; Keashly R
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):532-8. PubMed ID: 1711617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes.
    Slawsky MT; Castle NA
    J Pharmacol Exp Ther; 1994 Apr; 269(1):66-74. PubMed ID: 8169853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.
    Dinh H; Baker BJ; de Soyza N; Murphy ML
    Am Heart J; 1988 Jan; 115(1 Pt 1):92-6. PubMed ID: 3336989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of propafenone on premature ventricular contractions (PVC): an analysis based on heart rate dependency of PVCs.
    Saikawa T; Niwa H; Ito M; Ishida S; Nakagawa M; Maeda T; Takeshita Y; Takakura T; Sakata T
    Jpn Heart J; 2001 Nov; 42(6):701-11. PubMed ID: 11933920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinidine syncope: torsade de pointes with low quinidine plasma concentrations.
    Jenzer HR; Hagemeijer F
    Eur J Cardiol; 1976 Dec; 4(4):447-51. PubMed ID: 63370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetically-determined interaction between propafenone and low dose quinidine: role of active metabolites in modulating net drug effect.
    Funck-Brentano C; Kroemer HK; Pavlou H; Woosley RL; Roden DM
    Br J Clin Pharmacol; 1989 Apr; 27(4):435-44. PubMed ID: 2719900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of mexiletine in the medium-term treatment of ventricular arrhythmias. A randomized, double-blind, crossover trial against placebo in ambulatory patients.
    Masotti G; Morettini A; Casolo GC; Ieri A; Zipoli A; Serneri GG
    J Int Med Res; 1984; 12(2):73-80. PubMed ID: 6202571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of cardiac arrhythmias in the aged and their treatment with propafenone controlled by plasma level].
    Lachnit KS; Rieder L
    Z Gerontol; 1985; 18(6):343-52. PubMed ID: 2420079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mexiletine and propafenone: a comparative study of monotherapy, low, and full dose combination therapy.
    Takanaka C; Nonokawa M; Machii T; Lee S; Kato H; Haruna M; Yabe S
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2130-3. PubMed ID: 1279613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of ventricular tachycardia with propafenone. Parallel study of ventricular provocation tests].
    Faućhier JP; Rouesnel P; Cosnay P; Moquet B; Huguet R; Van Viet H; Balleh H
    Arch Mal Coeur Vaiss; 1987 Sep; 80(10):1523-31. PubMed ID: 3125812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.